Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Option Award |
2025-02-26 5:33 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
149,180 | $0 | 315,538 (Direct) |
View |
| 2025-02-25 Tax Withholding |
2025-02-26 5:33 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
507 | $0.9561 | 315,538 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:33 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
705 | $1 | 315,538 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
30,456 | $1.15 | 167,570 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
505 | $1.94 | 201,863 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:10 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
721 | $1.88 | 201,863 (Direct) |
View |
Ownership |
2024-10-28 4:11 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology |
0 | $0 | 380,002 (Direct) |
View |